[DISCLOSURE] MGmed (180400) said on Oct. 12 that it has decided on a capital increase of 8 billion won (US$7.1 million) through third-party allotment for investment purposes.
The shares will be issued to Korea Investment & Securities and Platform Partners Asset Management.


